PR inside: Marijuana Rescheduling Halted as GAO Report Puts Federal Evaluation ...
(PR-inside.com) Government Accountability Office Exposes Deficiencies in DEA and FDA Marijuana Rescheduling Procedures Behind Department of Health Human Services Recommendation; Judge Halts Broader Marijuana Rescheduling
WASHINGTON, D.C. / ACCESS Newswire / September 30, 2026 / MMJ International Holdings, Inc. ("MMJ"), a pharmaceutical developer pursuing FDA approval of cannabinoid medicines for Huntington's disease and multiple sclerosis, today highlighted the September 29 order by DEA Chief Administrative Law Judge Derek C. Julius staying the pending proceeding on broader marijuana rescheduling.
The hearing concluded July 15, and post-hearing briefs were filed August 17. The next anticipated step was the judge's recommended decision. Instead, the proceeding has ..
https://reports.pr-inside.com/marijuana ... 228959.htm
Copyright PR-Inside.com 2026
